Analysis for the prediction of systemic therapies in patients with locally advanced hepatocellular carcinoma
- Conditions
- Neoplasms
- Registration Number
- KCT0004206
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Patients with histologically confirmed locally advanced or metastatic HCC, which was judged not to be eligible for surgical resection, liver transplantation or radiofrequency ablation
Exclusion Criteria
Patients with histologically confirmed fibrolamellar type HCC or combined type with cholangiocarcinoma
Patients who refuse to participate in the study
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Objective response (complete response rate + partial response rate)
- Secondary Outcome Measures
Name Time Method Treatment response duration;Disease control rate;Time to progression;Progression free survival;Overall survival